Author
Kumar Navinit
Bio: Kumar Navinit is an academic researcher. The author has co-authored 1 publications.
Papers
More filters
19 Aug 2021
TL;DR: The bioavailability of nano-carriers depends upon various factors including their mode of administration, target specificity, availability of active compound and compatibility with biological system as mentioned in this paper. But, their bioavailability is not as good as that of conventional drugs.
Abstract: Nanomaterials in drug delivery systems are emerging as a potential source of treatments. The bioavailability of nano-carriers depends upon various factors including their mode of administration, target specificity, availability of active compound and compatibility with biological system.
1 citations
Cited by
More filters
TL;DR: This review summarizes current insights of Metal-Containing NPs in treating MRSA and provides an in-depth appraisal of opportunities and challenges in utilizing metal-NPs to treat MRSA.
Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of pneumonia in humans, and it is associated with high morbidity and mortality rates, especially in immunocompromised patients. Its high rate of multidrug resistance led to an exploration of novel antimicrobials. Metal nanoparticles have shown potent antibacterial activity, thus instigating their application in MRSA. This review summarizes current insights of Metal-Containing NPs in treating MRSA. This review also provides an in-depth appraisal of opportunities and challenges in utilizing metal-NPs to treat MRSA.
3 citations